Tirzepatide (Tirz) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed for advanced research into metabolic disorders, glucose regulation, and body weight management. Its dual-action mechanism enhances insulin secretion, improves insulin sensitivity, and promotes appetite suppression, making it a valuable compound for preclinical metabolic studies.

Research Applications & Potential Effects:

• Studies on blood glucose regulation and insulin resistance

• Research into appetite suppression and caloric intake reduction

• Evaluation of dual incretin action in obesity and diabetes models

• Preclinical investigations into cardiovascular and metabolic health

Supplied as a sterile, lyophilised powder in liquid to ensure maximum stability and purity for controlled laboratory use.

Molecular Formula: C225H348N48O68
Molar Mass: 4813.52 g/mol
Form: Lyophilised powder in liquid
Purity: ≥ 99% (HPLC)
Storage: Store at −20 °C, protect from light
Intended Use: Strictly for research purposes only. Not for human consumption, medical, or veterinary use.
CAS Number: 2023788-19-2